PRODUCT

GHRP-2 (5 mg Vial)

No short description available.

Quickstart Highlights

GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors[1]. Clinical studies predominantly employ once-daily subcutaneous administration to elicit robust pulsatile GH release while minimizing receptor desensitization[2][3]. This educational protocol presents a practical gradual titration approach with clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
Typical daily range: 100–300 mcg once daily subcutaneously.
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl or roll until completely dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Stimulate endogenous growth hormone secretion through ghrelin receptor activation[1].
Schedule:Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range:100–300 mcg daily with gradual titration; higher doses show dose-dependent responses but may offer limited added benefit with routine use[4].
Reconstitution:3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
Storage:Lyophilized frozen; reconstituted refrigerated (use within 2–3 weeks for optimal integrity).

Dosage Protocols

Start:100 mcg daily (Weeks 1–2); this starting dose provides strong GH pulse while allowing tolerance assessment.
Target:200 mcg daily (Weeks 5–16) for maximal effect in most research scenarios; advanced researchers may optionally increase to 250–300 mcg.
Frequency:Once per day (subcutaneous); evening administration may align with nocturnal GH rhythms.
Cycle Length:8–16 weeks; some attenuation may occur in first 1–2 weeks but response stabilizes with continued dosing[3].

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) in dry, dark conditions; powder is stable at room temperature for short periods but freezer storage maximizes shelf life[8].
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–3 weeks for optimal integrity[9]. For longer storage, consider aliquoting and freezing at −20 °C (−4 °F) with carrier protein; avoid repeated freeze–thaw cycles.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipodystrophy[13].
Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis[3]; once-daily administration avoids this issue.
Multiple daily injections (2–3×) have been explored but require strict adherence and may offer limited added benefit[5][6].
Document daily dose and site rotation to maintain consistency.

How It Works

GHRP-2 is a synthetic growth hormone secretagogue that binds to and activates ghrelin (GH secretagogue) receptors[1]. This activation triggers potent, pulsatile release of growth hormone from the pituitary gland in a dose-dependent manner[4]. Clinical studies in GH-deficient children demonstrated meaningful GH increases even at low doses (0.3–3.0 mcg/kg), with escalating doses over several months showing sustained efficacy[2]. In healthy adults, doses of 100 mcg SC daily produce acute GH stimulation[3], while routine protocols typically maintain 100–300 mcg/day to balance efficacy with receptor sensitivity. The peptide has been well tolerated in clinical trials with no significant adverse effects or toxicity reported at these dosage ranges[2][7].

Lifestyle Factors

Maintain adequate protein intake and balanced nutrition to support the anabolic effects of elevated GH.
Combine with resistance training to maximize body composition benefits.
Prioritize sleep quality, as GH pulses naturally occur during deep sleep; evening administration may complement this rhythm.
Manage stress effectively to support consistent adherence and recovery.
Stay well hydrated to support metabolic processes.

Injection Technique

Clean the vial rubber stopper and skin with alcohol swabs; allow to dry completely.
Use a fine insulin syringe (typically 29–31 gauge, 0.5-inch needle).
Pinch an inch of skin fat (abdomen, thigh, or outer upper arm); insert needle at 45° to 90° into subcutaneous tissue[11][12]. (Use 90° angle if ample fatty tissue; 45° for leaner individuals to avoid intramuscular injection.)
Do not aspirate for subcutaneous injections—aspiration is unnecessary and can cause needless tissue trauma[11][12].
Inject slowly and steadily; wait a few seconds before withdrawing needle at same angle.
Apply gentle pressure with swab if needed; do not massage or rub injection site.
Rotate sites systematically to prevent irritation and lipodystrophy—space injections at least 1 inch apart[13].

Benefits and Side Effects

Benefits

Stimulates robust pulsatile GH release that may support favorable body composition changes and metabolic effects[1][2].
In combination therapies (e.g., with GHRH analogs), can significantly increase IGF-1 levels when administered with perfect compliance[5][6].

Side Effects

Long-term therapy (8–24 months in GH-deficient subjects) has maintained positive effects on growth velocity with careful monitoring[2].
Occasional mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.

GHRP-2 (5 mg Vial)

Resources

Categories

Company